We serve Chemical Name:2-(4-Ethylphenyl)ethanamine CAS:64353-29-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(4-Ethylphenyl)ethanamine
CAS.NO:64353-29-3
Synonyms:2-(4-Ethylphenyl)ethanamine;Benzeneethanamine, 4-ethyl-;MFCD00079757
Molecular Formula:C10H15N
Molecular Weight:149.233
HS Code:2921499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:237.1±9.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.528
PSA:26.02000
Exact Mass:149.120453
LogP:2.45
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2735 8/PG 2
Packing Group:
Contact us for information like 2-(4-Ethylphenyl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00079757 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzeneethanamine, 4-ethyl- Use and application,MFCD00079757 technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications. 2-(4-Ethylphenyl)ethanamine manufacturer What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. 2-(4-Ethylphenyl)ethanamine supplier Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications. 2-(4-Ethylphenyl)ethanamine vendor Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing. 2-(4-Ethylphenyl)ethanamine factory Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.
